‘Bloody interesting companies’ deliver for Woodford
Immunocore leads trio of positive updates from the Patient Capital Trust
Equities
-
-
Days of defensive tobacco go up in smoke
US regulatory clamp down adds to disruption already hitting the sector
-
Polar Capital Japan manager heads to Paris office
Gerard Cawley is the only fund manager based in the European outpost
-
Nick Train: There is no bubble for central banks to burst
FTSE yield is high and capital gains meagre, says UK equity manager
-
Blackrock Emerging Europe investors swap into Frontiers
Frontiers investment trust holds just a fifth of its portfolio in Europe
-
US mid-terms could spark infrastructure spend
A better balance of power could lead to a stable infrastructure plan
-
Morningstar slams hidden backers behind anti-ESG campaign
SEC proxy voting review accused of being influenced by corporate interests
-
Vontobel EM debt fund needs longer to prove its worth
Blended fund has fallen less than the index in the year to date
-
Seven investors on what to look out for in the US midterms
Democrats and Republicans face off on 6 November
-
Woodford: Consensus on UK growth will be wrong again in 2019
UK equities manager says Budget 2018 painted a sunny outlook for the economy
-
Scottish Mortgage rakes in 419% from unlisted companies
Alibaba and Spotify among the investment trust’s successful picks
-
Rival Blackrock joins Jupiter short-sellers
Jupiter’s share price has halved year-to-date